Contract HHSD2122012M50073P
Experimental Pathology Laboratories, Inc. · Department Of Health And Human Services · February 17, 2012
Experimental Pathology Laboratories, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on February 17, 2012 for $10,000 of work in research and development in biotechnology. Performance is in Sterling, VA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSD2122012M50073P
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Support- Professional: Other
- Place of performance
- Sterling, VA
- First action
- February 17, 2012
Description
PATHOLOGY OF TISSUE SAMPLES
Modification timeline
-
February 17, 2012Base award$9.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2122012M50073P?
Contract HHSD2122012M50073P is a federal contract awarded to Experimental Pathology Laboratories, Inc. by Department Of Health And Human Services on February 17, 2012 for $10,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSD2122012M50073P?
Experimental Pathology Laboratories, Inc. won contract HHSD2122012M50073P from Department Of Health And Human Services.
How much is contract HHSD2122012M50073P worth?
Contract HHSD2122012M50073P has obligated $10,000 to date.